Stockscreener 앱 받기
12.29
8.69%
-1.17
시간 외 거래:
13.00
0.71
+5.78%
전일 마감가:
$13.46
열려 있는:
$14.05
하루 거래량:
1.96M
Relative Volume:
1.39
시가총액:
$569.58M
수익:
$217.11M
순이익/손실:
$-651.19M
주가수익비율:
-0.9461
EPS:
-12.99
순현금흐름:
$-387.26M
1주 성능:
+0.82%
1개월 성능:
+10.42%
6개월 성능:
-13.75%
1년 성능:
+7.51%
1일 변동 폭
$12.09
$14.05
1주일 범위
$12.09
$14.72
52주 변동 폭
$5.00
$16.85
깅코 바이오웍스 홀딩스 Stock (DNA) Company Profile
명칭
Ginkgo Bioworks Holdings Inc
전화
(877) 442-5362
주소
27 DRYDOCK AVENUE, BOSTON
DNA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DNA
Ginkgo Bioworks Holdings Inc
|
12.29 | 817.11M | 217.11M | -651.19M | -387.26M | -12.99 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
깅코 바이오웍스 홀딩스 Stock (DNA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-05-15 | 다운그레이드 | BTIG Research | Neutral → Sell |
| 2024-05-10 | 다운그레이드 | William Blair | Mkt Perform → Underperform |
| 2023-11-14 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2023-11-09 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2023-06-02 | 다운그레이드 | Goldman | Neutral → Sell |
| 2023-05-11 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2022-11-29 | 개시 | Berenberg | Buy |
| 2022-10-04 | 개시 | Morgan Stanley | Equal-Weight |
| 2022-05-18 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2022-03-02 | 재개 | Cowen | Outperform |
| 2022-02-23 | 개시 | Goldman | Neutral |
| 2022-02-01 | 개시 | BofA Securities | Neutral |
| 2022-01-28 | 개시 | BofA Securities | Buy |
| 2022-01-07 | 개시 | BTIG Research | Buy |
| 2021-11-29 | 개시 | Jefferies | Buy |
| 2021-10-13 | 개시 | Raymond James | Outperform |
| 2021-10-12 | 개시 | William Blair | Outperform |
| 2021-09-20 | 개시 | HSBC Securities | Buy |
모두보기
깅코 바이오웍스 홀딩스 주식(DNA)의 최신 뉴스
Comparing Ginkgo Bioworks Holdings Inc. in custom built stock radarsFree Swing Trade Entry With Volume Triggers - Newser
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Released Earnings Last Week And Analysts Lifted Their Price Target To US$10.33 - uk.finance.yahoo.com
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Q2 2025 Earnings Call Transcript - Insider Monkey
Ginkgo achieves $250M cost-reduction goal early, bolsters financial position - The Business Journals
Ginkgo Bioworks stock price target raised to $16 from $12 at TD Cowen - Investing.com Australia
Ginkgo Bioworks Holdings Inc (DNA) PT Raised to $16 at TD Cowen - StreetInsider
Ginkgo Bioworks Holdings Inc (DNA) Q2 2025 Earnings Call Highlights: Strategic Cost Management ... By GuruFocus - Investing.com Canada
Ginkgo Bioworks Holdings, Inc. 2025 Q2ResultsEarnings Call Presentation (NYSE:DNA) - Seeking Alpha
Ginkgo Bioworks Reports Q2 2025 Financial Results - TipRanks
Ginkgo Bioworks Holdings Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Ginkgo Bioworks Q2 2025 Earnings Call Transcript - MarketBeat
Ginkgo Bioworks Holdings: Strong Growth Potential Amidst Biosecurity Revenue Challenges - TipRanks
Ginkgo Bioworks Struggles As Biosecurity Revenue Slips - Finimize
Ginkgo Bioworks Holdings, Inc. SEC 10-Q Report - TradingView
Ginkgo Bioworks Reports Second Quarter 2025 Financial Results - TradingView
Ginkgo Bioworks Announces Q2 Earnings Presentation on Aug. 7, 2025 - AInvest
Bank of New York Mellon Corp Raises Holdings in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - Defense World
What makes Ginkgo Bioworks Holdings Inc. stock price move sharplyTechnical Reversal Setup with Risk Limits - Newser
Ginkgo Bioworks Holdings Inc expected to post a loss of $1.57 a shareEarnings Preview - TradingView
Ginkgo Bioworks Holdings Inc (DNA) Stock: A Year of Decreases and Increases - investchronicle.com
Quant Strategy Flags Ginkgo Bioworks Holdings Inc. for EntryLow Risk Buy Zone Opportunity Watch Ongoing - metal.it
Traders Consider Averaging Down in Ginkgo Bioworks Holdings Inc.Secure Return Focused Investment Plan Released - beatles.ru
How does Ginkgo Bioworks Holdings Inc. generate profit in a changing economyFree Investment Risk Control - Jammu Links News
Ginkgo Bioworks Holdings Inc. Stock Analysis and ForecastAccelerated wealth expansion - Jammu Links News
What catalysts could drive Ginkgo Bioworks Holdings Inc. stock higher in 2025Master stock selection with insider knowledge - Jammu Links News
What is the dividend policy of Ginkgo Bioworks Holdings Inc. stockExceptional profit potential - Jammu Links News
When is Ginkgo Bioworks Holdings Inc. stock expected to show significant growthGet alerts on the hottest stocks daily - Jammu Links News
Is it the right time to buy Ginkgo Bioworks Holdings Inc. stockBreakneck growth rates - Jammu Links News
How does Ginkgo Bioworks Holdings Inc. compare to its industry peersAchieve impressive returns with smart timing - Jammu Links News
What is the risk reward ratio of investing in Ginkgo Bioworks Holdings Inc. stockReal Time Planner For Fast Growth - jammulinksnews.com
Is Ginkgo Bioworks Holdings Inc. stock overvalued or undervaluedBeginner Investor Watchlist For 2025 - Jammu Links News
Ginkgo Bioworks shares fall 6.39% premarket ahead of Q2 2025 earnings presentation. - AInvest
Does Ginkgo Bioworks Holdings Inc. stock perform well during market downturnsAdvanced Screener Alerts That Work - Jammu Links News
Ginkgo Bioworks awarded $4.66M contract by PNNL - Yahoo Finance
Ginkgo Bioworks Announces Date of Second Quarter 2025 Results Presentation - 富途牛牛
Ginkgo Bioworks Q2 Earnings: Biosecurity Leader Sets August 7 Investor Call with Interactive Q&A - Stock Titan
Ginkgo Bioworks stock rises after securing $4.66M automation contract By Investing.com - Investing.com Canada
Ginkgo Bioworks Secures $4.66M Federal Contract for Revolutionary Lab Automation System at PNNL - Stock Titan
Ginkgo to Deploy Modular Automation Technology to the Environmental Molecular Sciences Laboratory (EMSL) at Pacific Northwest National Labs (PNNL) to Accelerate Microbial Research for the Bioeconomy - Ariva
Ginkgo Bioworks Holdings Inc. Flashes Rebound Signal in Oversold ConditionInvestment Plan With Growth Optimization Finalized - metal.it
Ginkgo Bioworks Holdings Inc. Stock Flags Risk Zone in Volatility IndexEarly Breakout Entry Point Notifications Sent - beatles.ru
Ginkgo Bioworks Holdings Inc. Breaks Below Key Support LevelSecure Capital Picks With Upside Potential Tracked - metal.it
What are analysts’ price targets for Ginkgo Bioworks Holdings Inc. in the next 12 monthsMaximize gains with proven stock analysis - jammulinksnews.com
How strong is Ginkgo Bioworks Holdings Inc. company’s balance sheetStay informed with daily expert analysis - jammulinksnews.com
What are the latest earnings results for Ginkgo Bioworks Holdings Inc.Achieve rapid portfolio appreciation today - Jammu Links News
What institutional investors are buying Ginkgo Bioworks Holdings Inc. stockAchieve rapid wealth accumulation through smart investing - Jammu Links News
깅코 바이오웍스 홀딩스 (DNA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.24%
3.39%
자본화:
|
볼륨(24시간):